Press Releases
November 12, 2025
NurExone Secures over C$3.18 Million Through Accelerated Warrant Exercises
November 3, 2025
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
October 21, 2025
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
October 8, 2025
NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model
September 17, 2025
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
September 11, 2025
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private Placement Closing
September 9, 2025
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
August 28, 2025
NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
August 24, 2025
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
August 8, 2025